Abstract
Heart diseases or heart attacks are nowadays becoming more and more common,
and in fact, are one of the largest killing diseases worldwide. Heart attack
is caused by narrowing of or any blockage in the coronary arteries, which
supply blood to heart muscles. Stents used in the coronary arteries to keep
them open are called coronary stents, and due to intensity and the rate of
increase in the disease are also gaining importance.
The coronary stents market has come a long way and its journey has been marked
by growth as well as decline phases. Since the advent of drug-eluting stents
in the early 2000, the coronary stent market witnessed a spurt in growth. The
years 2006 and 2007 saw a significant decline in market revenues due to
release of some adverse clinical trial data that raised questions about the
efficacy and safety of drug-eluting stents. 2008 again showed some stability.
The Percutaneous coronary intervention (PCI) procedures and the use of
drug-eluting stents (DES) in those procedures, implying the DES penetration
rate are the main indicators of growth of the DES market or the coronary
market at large. Bare metal stents (BMS) and drug-eluting stents are the two
types of coronary stents. Before the advent of DES, BMS were the only type of
stents available and hence covered the entire market. Since entry of DES, the
market has shifted almost entirely towards DES.
The report analyzes the coronary stent market from two perspectives. One is
from the point of products, i.e., BMS and DES market size, growth rate and
market share. Second is the size of the main regional stents market, like, the
US, Europe, Japan and Asia Pacific. The main factors driving the growth of the
market are also discussed along with the new developments in the market. The
competitive landscape of the market is also analyzed.
By combining SPSS Inc.' s data integration and analysis capabilities with our
relevant findings, we have predicted the future growth of the industry. We
employed various significant variables that have an impact on this industry
and created regression models with SPSS Base to determine the future direction
of the industry. Before deploying the regression model, the relationship
between several independent or predictor variables and the dependent variable
was analyzed using standard SPSS output, including charts, tables and tests.
Table of Contents
1. Overview
- 1.1 CABG
- 1.2 Angioplasty
- 1.3 Stents
2. Coronary Stent Market
- 2.1 Global Coronary Stent Market
- 2.1.1 Market Value & Growth
- 2.1.2 Bare Metal Stents (BMS) Market
- 2.1.3 Drug-eluting Stents (DES) Market
- 2.1.4 Penetration Rate
- 2.1.5 Market Share
- 2.2 US Coronary Stent Market
- 2.2.1 DES Market Value & Growth
- 2.2.2 Market Share
- 2.2.3 Pricing Trend
- 2.3 Asia-Pacific Coronary Stent Market
- 2.3.1 DES Penetration
- 2.3.2 Growth Rate
- 2.4 China Coronary Stent Market
- 2.4.1 DES Market Value
- 2.4.2 Market Share
- 2.5 Japan Coronary Stent Market
- 2.5.1 DES Market Growth
- 2.5.2 BMS Market Growth
- 2.5.3 Market Share
- 2.6 European Coronary Stent Market
- 2.6.1 DES Market Growth
- 2.6.2 BMS Market Growth
- 2.6.3 Market Share
- 2.7 Rest of World (ROW)
- 2.7.1 DES Market Growth
- 2.7.2 BMS Market Growth
- 2.7.3 Market Share
3. Market Dynamics
- 3.1 Market Drivers
- 3.1.1 High Obesity Rate
- 3.1.2 Aging population
- 3.1.3 Minimally Invasive Surgery
- 3.1.4 Hybrid Coronary Intervention
- 3.2 Market Developments
- 3.2.1 Bioabsorbable Stents
4. Market Players and Competition
- 4.1 Leading Players
- 4.2 Current Market Share
- 4.3 Market Share Forecast
5. Company Profiles
- 5.1 Boston Scientific
- 5.1.1 Overview
- 5.1.2 Business Strategies
- 5.1.3 Commitment to Quality
- 5.1.4 Financial Strength
- 5.2 Johnson & Johnson (Cordis Corporation)
- 5.2.1 Overview
- 5.2.2 Business Strategies
- 5.2.3 Healthcare Strategy
- 5.2.4 Accelerating Growth in Emerging Markets
- 5.3 Abbott Laboratories
- 5.3.1 Overview
- 5.3.2 Business Strategies
- 5.3.3 Diverse Mix of Business Portfolio
- 5.3.4 Depth & Strength across Businesses
- 5.4 Medtronic, Inc.
- 5.4.1 Overview
- 5.4.2 Business Strategies
- 5.4.3 Strengthening Financial Position
- 5.4.4 Commitment to Innovation
6. Market Outlook
- 6.1 Market Forecast
- 6.2 Forecast Methodology
- 6.2.1 Independent Variables
- 6.2.2 Correlation Analysis
- 6.2.3 Regression Analysis
List of Tables
- Global DES Market Share Quarterly Growth (2008)
- US DES Market Share Quarterly Growth (2008)
- US DES Month-wise Market Share of Vendors (2006)
- DES Offerings of Leading Players
- Global DES Market Share Growth Forecast (2008-10E)
- US DES Market Share Growth Forecast (2008-10E)
- Value of Dependent Variable (2002-08)
- Value of Independent Variable (2002-08)
- Correlation Table
- Model Summary - Coefficient of Determination
- Regression Table - Summary of Coefficients
List of Charts
- Treatment of Coronary Arteries Blockage
- Global Coronary Stent Market Growth (1995-2010E)
- Global DES Market Volume & Growth Rate (2006-10E)
- Global Quarterly DES Market Size & Growth (2008)
- Global Market Growth of BMS & DES (2002-08)
- Global PCI Procedure Volume (2007-08)
- Global Quarterly PCI Procedure Volume Growth (2008-09)
- Global DES Penetration Rate (2006-08)
- Global Quarterly DES Penetration Rate (2008-09)
- Global PCTA Procedures & Stent Procedures (2002-10E)
- BMS Vs. DES PCTA Procedures (2002-10E)
- Global DES Market by Region (2007)
- Global Market Share of Drug Coated Coronary Stent (June 2008)
- Global Market Share of DES Revenues (Q208)
- Global DES Market Share (2008)
- US DES Monthly Utilization Rate (2006-07)
- US Quarterly DES Market Size & Growth (2008)
- US DES Market Volume & Growth Rate (2006-08)
- US DES Market Share (2008)
- US DES Average Market Share by Usage (2006)
- US BMS & DES Average Selling Price (2002-10E)
- Healthcare Demand Comparison of Key Markets in Asia-Pacific (2015 vs. 2007)
- Revenue Contribution of Key Markets in Asia Pacific (2007)
- DES Penetration in Asia-Pacific (2006-07)
- Growth in Key Asia-Pacific (1H' 07/1H' 06)
- China DES Market Size (2006-07)
- China DES Market Share (1H' 2007)
- Japan BMS & DES Average Selling Price (2002-10E)
- Japan BMS & DES Market Growth (2002-10E)
- European BMS & DES Market Growth (2002-10E)
- European BMS & DES Average Selling Price (2002-10E)
- ROW BMS & DES Market Growth (2002-10E)
- ROW BMS & DES Average Selling Price (2002-10E)
- Segments of US Minimally Invasive Surgery Products (2007)
- Sales growth of Boston Scientific, 2004-2008
- Medical Devices & Diagnostic Sales growth of J&J, 2003-2007
- Sales Growth of Abbott Laboratories (2004-08)
- Sales Growth of Medtronic (2004-08)
- Global Coronary Stent Market Growth Forecast (2008-15E)
| 
